Regeneron Pharmaceuticals (REGN) EV to EBIT (2012 - 2026)
Regeneron Pharmaceuticals' EV to EBIT was 14.60 in Q2 2026, up 17.5% from 12.42 a year earlier but down 26.0% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) EV to EBIT (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Regeneron Pharmaceuticals' EV to EBIT was 7.88 through Jun 30, 2026, up 47.4% year-over-year; for FY2025, it came in at 20.16, up 18.6% from FY2024.
- In earlier years, EV to EBIT was 17.00 in FY2024 (-17.0%), 20.48 in FY2023 (+39.6%), 14.67 in FY2022 (+77.4%) and 8.27 in FY2021 (-46.3%).
- Quarterly EV to EBIT has moved between 8.27 (Q4 2021) and 26.58 (Q2 2024) over five years.
- Compared with a year earlier, EV to EBIT has increased for three straight quarters, with an average decline of 6.1% over the last eight quarters.
- The best year-over-year quarter for EV to EBIT over five years was Q1 2023 (growth of 97.8%); the worst was Q3 2021 (a decline of 55.4%).
- Per Business Quant data, REGN's EV to EBIT in the three quarters before Q2 2026 was 19.73 (Q1 2026), 20.16 (Q4 2025) and 13.50 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.60 |
| Mar 31, 2026 | 19.73 |
| Dec 31, 2025 | 20.16 |
| Sep 30, 2025 | 13.50 |
| Jun 30, 2025 | 12.42 |
| Mar 31, 2025 | 15.48 |
| Dec 31, 2024 | 17.00 |
| Sep 30, 2024 | 26.13 |
| Jun 30, 2024 | 26.58 |
| Mar 31, 2024 | 24.21 |
| Dec 31, 2023 | 20.48 |
| Sep 30, 2023 | 18.38 |
| Jun 30, 2023 | 15.68 |
| Mar 31, 2023 | 17.85 |
| Dec 31, 2022 | 14.67 |
| Sep 30, 2022 | 10.69 |
| Jun 30, 2022 | 9.96 |
| Mar 31, 2022 | 9.03 |
| Dec 31, 2021 | 8.27 |
| Sep 30, 2021 | 9.31 |
API Access
Regeneron Pharmaceuticals EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();